🇺🇸 Depakote DR in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 14

Most-reported reactions

1. Fall — 2 reports (14.29%)
2. Pain — 2 reports (14.29%)
3. Psychotic Disorder — 2 reports (14.29%)
4. Unresponsive To Stimuli — 2 reports (14.29%)
5. Abdominal Pain Upper — 1 report (7.14%)
6. Aggression — 1 report (7.14%)
7. Agitation — 1 report (7.14%)
8. Angioedema — 1 report (7.14%)
9. Anxiety — 1 report (7.14%)
10. Asthma — 1 report (7.14%)

Source database →

Frequently asked questions

Is Depakote DR approved in United States?

Depakote DR does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Depakote DR in United States?

Massachusetts General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.